GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently emerging as a major focus in medical investigation, largely due to its impressive impact on controlling diseases such as type 2 diabetes and excess body fat. Recent trials have revealed that in addition to glucose regulation, GLP-1 agonists offer potential for circulatory well